WAM
LAB icon

Wolverine Asset Management’s Standard BioTools LAB Stock Holding History

Wolverine Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$271 – 1719
2024
Q1 		$271 Hold
100
– – ﹤0.01% 1596
2023
Q4 		$221 Buy
+100
New +$213 ﹤0.01% 1701
2017
Q4 		– Sell
-129
Closed – – 1527
2017
Q3 		$0 Buy
+129
New +$542 ﹤0.01% 1435

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Wolverine Asset Management's LAB Position: Q2 2024 in Review

Wolverine Asset Management sold out of Standard BioTools (LAB) in Q2 2024, closing a stake of 100 shares — an estimated $271 sold.

Wolverine Asset Management first reported a position in LAB in Q3 2017 and held it in 3 quarters. The position peaked at $271 in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2024.

  • Wolverine Asset Management reported no remaining Standard BioTools position as of Q2 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 100 Standard BioTools shares in Q2 2024, an estimated $271.
  • Wolverine Asset Management first reported a position in Standard BioTools in Q3 2017 and held it in 3 quarters.
  • Wolverine Asset Management's Standard BioTools position peaked at $271 in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2024.

Based on Wolverine Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.